{"id":11336,"date":"2026-06-25T11:35:36","date_gmt":"2026-06-25T09:35:36","guid":{"rendered":"https:\/\/www.hartwigmedicalfoundation.nl\/?p=11336"},"modified":"2026-06-25T13:00:27","modified_gmt":"2026-06-25T11:00:27","slug":"biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment","status":"publish","type":"post","link":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/","title":{"rendered":"Biomarkers Reveal Which Cancer Patients Won\u2019t Benefit From Treatment"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><em>Researchers from Vall d&#8217;Hebron Institute of Oncology identify genomic signals predicting non-response to cancer therapies in collaboration with Hartwig Medical Foundation, underscoring the value of large real-world data collections<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Real<\/strong>&#8211;<strong>world cancer genomics reveals biomarkers of non<\/strong>&#8211;<strong>response<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Amsterdam, June 2026<\/strong>&nbsp;\u2014 <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2949820126000408\/\" target=\"_blank\" rel=\"noreferrer noopener\">A new study published in&nbsp;<em>ESMO Real World Data and Digital Oncology<\/em><\/a>&nbsp;demonstrates how systematically mining one of the world&#8217;s largest real-world cancer genomics databases can uncover biomarkers that predict which patients are unlikely to benefit from specific cancer treatments. The findings highlight that individual datasets don\u2019t suffice, and that&nbsp;pooling and re-analysing large, richly clinically annotated datasets is essential to make precision oncology truly precise. With the aim of protecting patients from unnecessary side effects and ineffective therapies, they are also effective.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Whole<\/strong>&#8211;<strong>genome and transcriptome sequencing across 7,000 metastatic tumors<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The study analyzed whole-genome and transcriptome sequencing data from the access-controlled Hartwig Medical database of more than 7,000 metastatic tumor genomes. Across 56 treatment cohorts and 2,663 candidate biomarkers, they&nbsp;applied a systematic statistical framework to identify genomic and transcriptomic features strongly associated with non-response to therapy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Key findings: immune evasion in melanoma and KRAS G12D in colorectal cancer<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The analysis revealed several clinically meaningful findings. In melanoma patients treated with immune checkpoint inhibitors, genomic drivers of immune evasion were associated with a complete absence of response, while in metastatic colorectal cancer, KRAS G12D mutations were linked to a response rate of just 5% across multiple chemotherapy regimens. Similarly, a multivariate classifier combining four independent molecular features \u2014 tumour mutational burden, T-cell infiltration, hedgehog signalling, and renin-angiotensin pathway expression \u2014 identified a subgroup of immunotherapy-treated patients, spanning multiple cancer types, with no observed responses. Together, these findings illustrate how integrating molecular markers can sharpen patient selection and help avoid ineffective treatments<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Non<\/strong>&#8211;<strong>response biomarkers can reduce toxicity and redirect patients to better options<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;Identifying patients who will not benefit from a treatment is just as important as identifying those who will,&#8221; said co-corresponding author Edwin Cuppen, Scientific Director of Hartwig Medical Foundation. <\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">&#8220;These non-responder biomarkers have direct value: they could spare patients needless toxicity and help redirect them to trials or alternative strategies more likely to help.&#8221; Edwin Cuppen, Scientific Director of Hartwig Medical Foundation.<\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why large<\/strong>&#8211;<strong>scale datasets are essential for discovering rare non<\/strong>&#8211;<strong>response signals<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Critically, the study also demonstrates why large, continuously growing datasets are indispensable. A power analysis revealed that reliably establishing a response rate below 5% for a biomarker requires at least 59 non-responder events \u2014 and for rare biomarkers, treatment matched cohorts of close to 1,000 patients or more. Most current treatment sub-cohorts fall well short of this threshold, meaning that the true potential of non-response biomarker discovery remains locked inside datasets that do not yet exist at sufficient scale.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Systematic re<\/strong>&#8211;<strong>analysis of harmonised real<\/strong>&#8211;<strong>world data enables sustainable genomic medicine<\/strong><\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">&#8220;This work shows both what is already possible and what becomes possible as data accumulates,&#8221; <\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\">said co-corresponding author Francisco Mart\u00ednez-Jim\u00e9nez, Group Leader at VHIO and Data Mining Lead at Hartwig Medical Foundation.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">&#8220;Systematic re-analysis of large, harmonised real-world datasets is not just scientifically valuable \u2014 it is the path to making genomic medicine sustainable and equitable.&#8221; Francisco Mart\u00ednez-Jim\u00e9nez<\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Call for federated data<\/strong>&#8211;<strong>sharing to accelerate precision oncology<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The authors call for expanded federated data-sharing infrastructures that integrate harmonized sequencing protocols and clinical annotations across institutions and countries, enabling the kind of scale needed to confidently translate non-response signals into clinical decision-making.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Data from the Hartwig Medical database underpinning this study are freely accessible to researchers via a data access request at&nbsp;<a href=\"https:\/\/eur05.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.hartwigmedicalfoundation.nl%2Fen%2Fdata%2Fdata-access-request%2F&amp;data=05%7C02%7Cf.martinezjimenez%40hartwigmedicalfoundation.nl%7C09a87e105ff3491b4c4708ded11ee9d6%7C9fdddc888371407c9f46a695b3ab0c2b%7C0%7C0%7C639178127851304029%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=P%2BbWiY7NCtqnnZArbdnZCCLAno%2BSWzXk1%2Fehcxlex0w%3D&amp;reserved=0\">https:\/\/www.hartwigmedicalfoundation.nl\/en\/data\/data-access-request\/<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Researchers from Vall d&#8217;Hebron Institute of Oncology identify genomic signals predicting non-response to cancer therapies in collaboration with Hartwig Medical &hellip;<\/p>\n","protected":false},"author":15,"featured_media":11320,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[90,91,74,75,93,83,85,76,79,73,77,80],"tags":[],"class_list":["post-11336","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-algorithms","category-biomarker","category-dna","category-hartwig-medical-database","category-hartwig-medical-foundation","category-it","category-learning-healthcare-system","category-molecular-diagnostics","category-onco-act","category-personalized-treatment","category-scientific-publications","category-whole-genome-sequencing"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biomarkers Reveal Which Cancer Patients Won\u2019t Benefit From Treatment - Hartwig Medical Foundation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biomarkers Reveal Which Cancer Patients Won\u2019t Benefit From Treatment - Hartwig Medical Foundation\" \/>\n<meta property=\"og:description\" content=\"Researchers from Vall d&#8217;Hebron Institute of Oncology identify genomic signals predicting non-response to cancer therapies in collaboration with Hartwig Medical &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Hartwig Medical Foundation\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-25T09:35:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-25T11:00:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2026\/06\/DNA-kankercel-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Bruna Venturinelli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bruna Venturinelli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\\\/\"},\"author\":{\"name\":\"Bruna Venturinelli\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#\\\/schema\\\/person\\\/7b7bf28d0bffa1159e98c8810f2b89ef\"},\"headline\":\"Biomarkers Reveal Which Cancer Patients Won\u2019t Benefit From Treatment\",\"datePublished\":\"2026-06-25T09:35:36+00:00\",\"dateModified\":\"2026-06-25T11:00:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\\\/\"},\"wordCount\":602,\"image\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/DNA-kankercel-scaled.jpg\",\"articleSection\":[\"Algorithms\",\"Biomarker\",\"DNA\",\"Hartwig Medical Database\",\"Hartwig Medical Foundation\",\"IT\",\"Learning healthcare system\",\"Molecular diagnostics\",\"OncoAct\",\"Personalized treatment\",\"Scientific publications\",\"Whole genome sequencing\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\\\/\",\"url\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\\\/\",\"name\":\"Biomarkers Reveal Which Cancer Patients Won\u2019t Benefit From Treatment - Hartwig Medical Foundation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/DNA-kankercel-scaled.jpg\",\"datePublished\":\"2026-06-25T09:35:36+00:00\",\"dateModified\":\"2026-06-25T11:00:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#\\\/schema\\\/person\\\/7b7bf28d0bffa1159e98c8810f2b89ef\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/DNA-kankercel-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/DNA-kankercel-scaled.jpg\",\"width\":2560,\"height\":1440,\"caption\":\"Kankercel en DNA-streng\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#website\",\"url\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/\",\"name\":\"Hartwig Medical Foundation\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#\\\/schema\\\/person\\\/7b7bf28d0bffa1159e98c8810f2b89ef\",\"name\":\"Bruna Venturinelli\",\"url\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/author\\\/bruna-venturinelli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biomarkers Reveal Which Cancer Patients Won\u2019t Benefit From Treatment - Hartwig Medical Foundation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/","og_locale":"en_US","og_type":"article","og_title":"Biomarkers Reveal Which Cancer Patients Won\u2019t Benefit From Treatment - Hartwig Medical Foundation","og_description":"Researchers from Vall d&#8217;Hebron Institute of Oncology identify genomic signals predicting non-response to cancer therapies in collaboration with Hartwig Medical &hellip;","og_url":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/","og_site_name":"Hartwig Medical Foundation","article_published_time":"2026-06-25T09:35:36+00:00","article_modified_time":"2026-06-25T11:00:27+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2026\/06\/DNA-kankercel-scaled.jpg","type":"image\/jpeg"}],"author":"Bruna Venturinelli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Bruna Venturinelli","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/#article","isPartOf":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/"},"author":{"name":"Bruna Venturinelli","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#\/schema\/person\/7b7bf28d0bffa1159e98c8810f2b89ef"},"headline":"Biomarkers Reveal Which Cancer Patients Won\u2019t Benefit From Treatment","datePublished":"2026-06-25T09:35:36+00:00","dateModified":"2026-06-25T11:00:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/"},"wordCount":602,"image":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2026\/06\/DNA-kankercel-scaled.jpg","articleSection":["Algorithms","Biomarker","DNA","Hartwig Medical Database","Hartwig Medical Foundation","IT","Learning healthcare system","Molecular diagnostics","OncoAct","Personalized treatment","Scientific publications","Whole genome sequencing"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/","url":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/","name":"Biomarkers Reveal Which Cancer Patients Won\u2019t Benefit From Treatment - Hartwig Medical Foundation","isPartOf":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/#primaryimage"},"image":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2026\/06\/DNA-kankercel-scaled.jpg","datePublished":"2026-06-25T09:35:36+00:00","dateModified":"2026-06-25T11:00:27+00:00","author":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#\/schema\/person\/7b7bf28d0bffa1159e98c8810f2b89ef"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/biomarkers-reveal-which-cancer-patients-wont-benefit-from-treatment\/#primaryimage","url":"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2026\/06\/DNA-kankercel-scaled.jpg","contentUrl":"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2026\/06\/DNA-kankercel-scaled.jpg","width":2560,"height":1440,"caption":"Kankercel en DNA-streng"},{"@type":"WebSite","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#website","url":"https:\/\/www.hartwigmedicalfoundation.nl\/","name":"Hartwig Medical Foundation","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hartwigmedicalfoundation.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#\/schema\/person\/7b7bf28d0bffa1159e98c8810f2b89ef","name":"Bruna Venturinelli","url":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/author\/bruna-venturinelli\/"}]}},"_links":{"self":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/posts\/11336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/comments?post=11336"}],"version-history":[{"count":4,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/posts\/11336\/revisions"}],"predecessor-version":[{"id":11348,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/posts\/11336\/revisions\/11348"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/media\/11320"}],"wp:attachment":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/media?parent=11336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/categories?post=11336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/tags?post=11336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}